SCHEMBL25819896

SCHEMBL25819896

O=C(O)c1ccc2nccc(Nc3cccc(C(=O)Nc4cccc(Nc5ccccc5)c4)c3)c2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 8/20 0.69
DNMT3A Q9Y6K1 7/20 0.69
DNMT3L Q9UJW3 4/20 0.57
EHMT1 Q9H9B1 2/20 0.57
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
MAPKAPK2 P49137 1/20 0.51
USP2 O75604 1/20 0.50
MAPT P10636 1/20 0.50
HDAC3 O15379 1/20 0.48
ACHE P22303 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
EGFR P00533 2/20 0.48
AKR1C4 P17516 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30290883 0.95 DNMT1 (0.62) DNMT1DNMT3ADNMT3LEHMT1KMT2A
SCHEMBL19151434 0.95 DNMT1 (0.62) DNMT1DNMT3ADNMT3LEHMT1KMT2A
SCHEMBL25819893 0.93 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1KMT2A
SCHEMBL25820577 0.92 DNMT1 (0.67) DNMT1DNMT3ADNMT3LEHMT1KMT2A
SCHEMBL24010248 0.91 DNMT1 (0.58) DNMT1DNMT3ADNMT3LEHMT1KMT2A
SCHEMBL30290841 0.91 DNMT1 (0.58) DNMT1DNMT3ADNMT3LEHMT1KMT2A
SCHEMBL25819895 0.90 DNMT1 (0.64) DNMT1DNMT3ADNMT3LEHMT1KMT2A
SCHEMBL25825393 0.89 DNMT1 (0.72) DNMT1DNMT3ADNMT3LEHMT1KMT2A
SCHEMBL25821699 0.89 DNMT1 (0.87) DNMT1DNMT3ADNMT3LEHMT1HDAC3
SCHEMBL30290755 0.88 DNMT1 (0.68) DNMT1DNMT3ADNMT3LEHMT1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219927-A1 AKT3 MODULATORS Georgiamune Inc. 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219927-A1 AKT3 MODULATORS AKT3, AKT2, PIK3CA DNMT1 4335/4885DNMT3A 4603/4885DNMT3L 4609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.